Comparability preview
Get your free board report →
Odylia Therapeutics Inc
EIN 822120760 · GA · NTEE H41 · revenue $482,047 · FY 2024-12-31
$
Pick the role and type the pay your board is considering — everything below updates as you type. We only compare against the same role.
97th percentile
We compared this Executive Director / CEO's pay to 152 similar medical research nonprofits of about the same size, adjusted for GA cost of living and inflation.
ASHLEY WINSLOW · reported title "CEO/CSO".
How we chose them
Every comparable organization in the band — 152 in total — matched by Same NTEE major group (H), nationwide + budget 0.67–1.5× revenue, and selected by rule, not hand-picked. Peer pay is normalized to GA cost of living (BEA Regional Price Parities) and to the subject's filing year (CPI-U). Full methodology →
| Organization | State | Revenue | Total comp | Filing |
|---|---|---|---|---|
| Parkinson Association Of | NC | $482,140 | $80,297 | 990 → |
| American Cochlear Implant Alliance | VA | $483,427 | $193,376 | 990 → |
| St Louis Life Sciences Project | MO | $479,877 | $218,888 | 990 → |
| American Board Of Medical Specialties | IL | $484,417 | $115,357 | 990 → |
| Global Vitiligo Foundation | PA | $478,511 | $85,459 | 990 → |
| 🔒 +147 more comparable organizations — the full peer set, sources, and CSV export are included in your board report. | ||||
Generate the board-ready determination
A formatted PDF with the full 152-organization peer set, the distribution, the methodology, and ready-to-adopt 26 CFR 53.4958-6 board-minutes language — timestamped to attach to your minutes. A screenshot of a webpage isn't board minutes. It's free for your organization's size.